Return to homepagePandemic Pact

Development of an Autologous Human Dendritic Cell Vaccine to Treat SARS-COV-2 501Y.V2: A Preclinical Trial

  • Funded by South African Medical Research Council (SAMRC)
  • Total publications:0 publications
Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $45,773.91

  • Funder

    South African Medical Research Council (SAMRC)

  • Principal Investigator

    N/A

  • Research Location

    South Africa

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract